Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marijke Peetermans

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|October 15, 2016
Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled "Idarucizumab for dabigatran overdose"Marijke Peetermans, Peter Verhamme
European Heart Journal. Acute Cardiovascular Care|February 9, 2024
Nutritional support in the cardiac intensive care unitPascal Frederiks, Marijke Peetermans, Alexander Wilmer
Seminars in Thrombosis and Hemostasis|May 15, 2015
Coagulase Activity by Staphylococcus aureus: A Potential Target for Therapy?Marijke Peetermans, Peter Verhamme, Thomas Vanassche
Chest|September 3, 2014
IgE sensitization to Aspergillus fumigatus is not a bystander phenomenon in cystic fibrosis lung diseaseMarijke Peetermans, Pieter Goeminne, Christiane De Boeck, et al.
Journal of Thrombosis and Thrombolysis|November 9, 2013
Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformationChristophe Vandenbriele, Thomas Vanassche, Marijke Peetermans, et al.
Intensive Care Medicine|February 17, 2025
Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: insights from daily clinical practiceIsabel Spriet, Matthias Gijsen, Marijke Peetermans, et al.
Critical Reviews in Microbiology|October 21, 2015
Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunityMarijke Peetermans, Thomas Vanassche, Laurens Liesenborghs, et al.
Expert Review of Cardiovascular Therapy|November 29, 2014
Monitoring and reversal strategies for new oral anticoagulantsSophie Vanden Daelen, Marijke Peetermans, Thomas Vanassche, et al.
Journal of Visualized Experiments : Jove|July 2, 2015
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow ConditionsJorien Claes, Laurens Liesenborghs, Marleen Lox, et al.
Heliyon|December 8, 2022
Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature reviewJona F Houthuys, Alexander P Wilmer, Marijke Peetermans, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Clinical Toxicology (Philadelphia, Pa.)|October 15, 2016
Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled "Idarucizumab for dabigatran overdose"Marijke Peetermans, Peter Verhamme
European Heart Journal. Acute Cardiovascular Care|February 9, 2024
Nutritional support in the cardiac intensive care unitPascal Frederiks, Marijke Peetermans, Alexander Wilmer
Seminars in Thrombosis and Hemostasis|May 15, 2015
Coagulase Activity by Staphylococcus aureus: A Potential Target for Therapy?Marijke Peetermans, Peter Verhamme, Thomas Vanassche
Chest|September 3, 2014
IgE sensitization to Aspergillus fumigatus is not a bystander phenomenon in cystic fibrosis lung diseaseMarijke Peetermans, Pieter Goeminne, Christiane De Boeck, et al.
Journal of Thrombosis and Thrombolysis|November 9, 2013
Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformationChristophe Vandenbriele, Thomas Vanassche, Marijke Peetermans, et al.
Intensive Care Medicine|February 17, 2025
Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: insights from daily clinical practiceIsabel Spriet, Matthias Gijsen, Marijke Peetermans, et al.
Critical Reviews in Microbiology|October 21, 2015
Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunityMarijke Peetermans, Thomas Vanassche, Laurens Liesenborghs, et al.
Expert Review of Cardiovascular Therapy|November 29, 2014
Monitoring and reversal strategies for new oral anticoagulantsSophie Vanden Daelen, Marijke Peetermans, Thomas Vanassche, et al.
Journal of Visualized Experiments : Jove|July 2, 2015
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow ConditionsJorien Claes, Laurens Liesenborghs, Marleen Lox, et al.
Heliyon|December 8, 2022
Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature reviewJona F Houthuys, Alexander P Wilmer, Marijke Peetermans, et al.
Pageof 5